1-8 of 8
Dixil Francis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma

Free
Clinical Trials & Observations
Paul G. Richardson, Wanling Xie, Sundar Jagannath, Andrzej Jakubowiak, Sagar Lonial, Noopur S. Raje, Melissa Alsina, Irene M. Ghobrial, Robert L. Schlossman, Nikhil C. Munshi, Amitabha Mazumder, David H. Vesole, Jonathan L. Kaufman, Kathleen Colson, Mary McKenney, Laura E. Lunde, John Feather, Michelle E. Maglio, Diane Warren, Dixil Francis, Teru Hideshima, Robert Knight, Dixie-Lee Esseltine, Constantine S. Mitsiades, Edie Weller, Kenneth C. Anderson
Journal: Blood
Blood (2014) 123 (10): 1461–1469.
https://doi.org/10.1182/blood-2013-07-517276
Published: 2014
Journal Articles

The Multiple Myeloma Research Consortium (MMRC) Model: Reduced Time to Trial Activation and Improved Accrual Metrics.

Free
Sandra Wear, RN, Paul G. Richardson, MD, Carolyn Revta, MPH, Ravi Vij, MBBS, MD, Mark Fiala, BS, CCRP, Sagar Lonial, MD, Dixil Francis, MPH, CCRC, David Samuel diCapua Siegel, MD, PhD, Alex Schramm, BA, Andrzej J. Jakubowiak, MD, PhD, Colleen K. Harvey, Donna E. Reece, MD, Engin Gul, HonBSc, Sundar Jagannath, MD, Lisa La, MS, Craig C. Hofmeister, MD, Buffy Jansak, BSN, OCN, Keith Stewart, MBA, MB, CHB, Rachel Hagerty, Jeffrey L. Wolf, MD, Beth Davis, Amrita Krishnan, MD, Lupe Duarte, CCRC, Todd M. Zimmerman, MD, Angela Cisneros, Shaji Kumar, MD, Ann Birgin, CRA, Robert Ott, MBA, Leah Tasca, Susan L. Kelley, MD, Kenneth C. Anderson, MD, Kathy Giusti, MBA
Journal: Blood
Blood (2010) 116 (21): 3803.
https://doi.org/10.1182/blood.V116.21.3803.3803
Published: 2010
Journal Articles

Lenalidomide, Bortezomib, and Dexamethasone (RVD) In Combination with Vorinostat as Front-Line Therapy for Patients with Multiple Myeloma (MM): Initial Results of a Phase 1 Study

Free
Jonathan L. Kaufman, MD, Jatin J Shah, MD, Jacob P. Laubach, MD, Leonard Heffner, MD, Dixil Francis, R. Donald Harvey, PharmD, Colleen Lewis, Mourad Tighiouart, Paul Richardson, Robert Z. Orlowski, MD, PhD, Sagar Lonial, MD
Journal: Blood
Blood (2010) 116 (21): 3034.
https://doi.org/10.1182/blood.V116.21.3034.3034
Published: 2010
Journal Articles

A Phase I Clinical Trial Testing the Combination of Bortezomib and Tipifarnib in Relapsed/Refractory Multiple Myeloma.

Free
Sagar Lonial, MD, Dixil Francis, MPH, Chatchada Karanes, Suzanne Trudel, MD, Akari M. Dollard, Fermin Aceo, Engin Gul, Sumeet Kakar, Amrita Y. Krishnan, MD, FACP, Donna E. Reece, MD, R. Donald Harvey, PharmD, Jonathan L. Kaufman, MD
Journal: Blood
Blood (2009) 114 (22): 3851.
https://doi.org/10.1182/blood.V114.22.3851.3851
Published: 2009
Journal Articles

Preliminary Results of a Phase I Study of the Pan-PI3 Kinase Inhibitor SF1126 in Patients with Relapsed and Refractory Myeloma.

Free
Sagar Lonial, MD, R. Donald Harvey, Pharm, D., Dixil Francis, MPH, Engin Gul, Sundar Jagannath, MD, Sherif Farag, MBBS, PhD, Daniel Hoth, MD, Robert Frumento, M.S., MPH, Joseph R. Garlich, PhD, Suzanne Trudel, MD
Journal: Blood
Blood (2009) 114 (22): 3879.
https://doi.org/10.1182/blood.V114.22.3879.3879
Published: 2009
Journal Articles

High Response Rates and Encouraging Time-to-Event Data with Lenalidomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Final Results of a Phase I/II Study.

Free
Paul G Richardson, Sagar Lonial, Andrzej J Jakubowiak, Sundar Jagannath, Noopur S Raje, David E Avigan, Irene Ghobrial, Robert L Schlossman, Amitabha Mazumder, Nikhil C. Munshi, Jacob Laubach, David Vesole, Robin Joyce, Jacalyn Rosenblatt, Wanling Xie, Deborah Doss, Diane L. Warren, Kate Ittleman, Carolyn Revta, Dixil Francis, Charles Leister, Sarah Kaster, Carol Delaney, Marisa Lauria, Constantine S. Mitsiades, Teru Hideshima, Robert Knight, Dixie-Lee Esseltine, Edie Weller, Kenneth C. Anderson
Journal: Blood
Blood (2009) 114 (22): 1218.
https://doi.org/10.1182/blood.V114.22.1218.1218
Published: 2009
Journal Articles

A Phase I MMRC Clinical Trial Testing the Combination of Bortezomib and Tipifarnib in Relapsed/Refractory Multiple Myeloma

Free
Sagar Lonial, MD, Dixil Francis, Chatchada Karanes, Suzanne Trudel, Donna E. Reece, MD, Amrita Krishnan, Marc Buacharern, Renee Smith, Faraz Zaman, Engin Gul, Akari M. Dollard, Donald Harvey, Jonathan Kaufman
Journal: Blood
Blood (2008) 112 (11): 3706.
https://doi.org/10.1182/blood.V112.11.3706.3706
Published: 2008
Journal Articles

Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma

Free
Clinical Trials & Observations
Sagar Lonial, Edmund K. Waller, Paul G. Richardson, Sundar Jagannath, Robert Z. Orlowski, Cynthia R. Giver, David L. Jaye, Dixil Francis, Sara Giusti, Claire Torre, Bart Barlogie, James R. Berenson, Seema Singhal, David P. Schenkein, Dixie-Lee W. Esseltine, Jessica Anderson, Hugh Xiao, Leonard T. Heffner, Kenneth C. Anderson, for the SUMMIT/CREST Investigators
Journal: Blood
Blood (2005) 106 (12): 3777–3784.
https://doi.org/10.1182/blood-2005-03-1173
Published: 2005